DiscoverJACC PodcastClinical implications of Pre-test probability of HFpEF on Outcomes in Precapillary Pulmonary Hypertension
Clinical implications of Pre-test probability of HFpEF on Outcomes in Precapillary Pulmonary Hypertension

Clinical implications of Pre-test probability of HFpEF on Outcomes in Precapillary Pulmonary Hypertension

Update: 2024-11-18
Share

Description

In this episode, Dr. Valentin Fuster reviews a recent study exploring the clinical overlap between heart failure with preserved ejection fraction (HFpEF) and Group 1 pulmonary hypertension. The study identifies a subset of patients with pulmonary hypertension who have a higher risk of heart failure and worse outcomes, emphasizing the need for further investigation into whether pulmonary hypertension therapies could improve prognosis in these patients.

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Clinical implications of Pre-test probability of HFpEF on Outcomes in Precapillary Pulmonary Hypertension

Clinical implications of Pre-test probability of HFpEF on Outcomes in Precapillary Pulmonary Hypertension